The Facilities for Medicare and Medicaid Solutions yesterday issued a proposed rule to get started eliminating boundaries to the progress of price-primarily based payment agreements in between drug makers and payers, together with Medicaid.
The rule would also propose modifications to existing laws dealing with how makers establish the rate of manufacturer identify medicines when there is an approved generic version also on the market place.
In addition, it proposes bare minimum standards in condition Medicaid Drug Utilization Evaluate packages designed to lower opioid-similar fraud, misuse, and abuse.
WHY IT Issues
Underneath existing laws, payers and makers generally foundation their